Tech Company Financing Transactions
Epigenetx Funding Round
On 3/31/2014, Epigenetx raised $170 thousand in funding from BioGenerator and private investors.
Transaction Overview
Company Name
Announced On
3/31/2014
Transaction Type
Venture Equity
Amount
$170,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4041 Forest Park Pkwy.
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Email Address
Not Recorded
Overview
Epigenetx, LLC offers a drug discovery and development platform. The company was incorporated in 2013 and is based in St. Louis, Missouri.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alan Macinnes
Chief Operating Officer
Robert Beardsley
Browse more venture capital transactions:
Prev: 3/31/2014: Craftyful venture capital transaction
Next: 3/31/2014: Cerephex venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs